GH vs MTD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GH · Guardant Health$150.87 ▼ 1.67%
MTD · Mettler-Toledo International$1,722.15 ▲ 2.57%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GH +54.1%
- MTD +20.2%
Head to head
| Metric | GH | MTD |
|---|---|---|
| Price | $150.87 | $1,722.15 |
| Change today | ▼ 1.67% | ▲ 2.57% |
| Market cap | $20.41B | $34.51B |
| Return, 3 months | -9.8% | +20.6% |
| Return, year to date | +47.7% | +23.5% |
| Return, 1 year | +56.0% | +19.6% |
| P/E (TTM) | – | 37.4 |
| P/B | -74.0 | 444.3 |
| P/E percentile vs own 5y | 8th | 69th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +44.3% | +4.5% |
| Net profit growth (YoY) | -20.3% | +15.1% |
| Gross margin | 65.0% | 60.3% |
| Operating margin | -39.7% | 28.4% |
| Net margin | -38.3% | 21.9% |
| Return on equity | – | – |
| Analyst target vs. price | +35.3% | -7.8% |
| Analyst buy share | 100% | 43% |
| RSI (14) | 37 | 66 |
| 30-day volatility | 55.1% | 24.1% |
| Max drawdown, 1 year | -33.0% | -31.9% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MTD is the largest of the group by market value.
- GH has returned the most over the past year.
- GH is growing revenue fastest.
- MTD keeps the most profit per dollar of sales.
- MTD has been the calmest stock over the last 30 days.